Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (232)

Latest Posts

About This Stock More About This Stock
J&J Beats On Q1 Earnings, Suspends COVID Jab Sales View
Article By: Zacks Investment Research
Tuesday, April 19, 2022 9:55 AM EDT
Johnson & Johnson’s first-quarter 2022 earnings came in at $2.67 per share.
In this article: JNJ Also: ABBV
Read
Keep An Eye On JNJ Today
Article By: Greg Feirman
Tuesday, April 19, 2022 5:21 AM EDT
Johnson & Johnson is reporting 1Q22 earnings in a couple of hours.
In this article: JNJ
Read
J&J To Set The Tone For Pharma Sector's Q1 Earnings
Article By: Zacks Investment Research
Monday, April 18, 2022 1:45 PM EDT
We expect Johnson & Johnson to beat expectations when it reports first-quarter 2022 results on Apr 19, before the market open.
In this article: JNJ
Read
This Is How To Make $1000/mo In Passive Income With Dividend Stocks
Video By: Rick Orford
Friday, April 8, 2022 4:07 AM EDT
Do you want to make $1000 a month in passive income? This covers 9 stocks that investors can buy and hold forever, along with a plan to get to the end line.
In this video: AWR, CL, DOV, EMR, JNJ, KO, MMM, PG, CINF
Watch
3 Buffett Stocks Worth Buying Right Now
Video By: Jason Fieber
Monday, April 4, 2022 6:52 AM EDT
Being invested alongside Warren Buffett is rarely a bad place to be. Instead, it's usually a fantastic place to be. Buffett oversees a $320 billion common stock portfolio through his conglomerate, Berkshire Hathaway Inc.
In this video: AAPL, JNJ, VZ
Watch

Latest Tweets for $JNJ

No tweets yet!

PARTNER HEADLINES

$JNJ

It's Good To Be A Guinea Pig
Harry Goldstein 4/15/2021 2:52:27 PM

It's crazy that they suspended the $JNJ vaccine because 6 people out of 7 million experience some adverse effects which did not even kill them. Meanwhile Covid has killed millions. Being that the JNJ vaccine had zero adverse effects in men, they should at least let me continue to get it. It's so hard to get vaccinated as is it.

How To Invest In Woman-Led Companies With ETFs & Stocks
Financial Zonked Talk 4/9/2019 4:45:28 AM

Not until they remove cancer causing $JNJ from portfolio.

Johnson & Johnson: Recession Safety, Growth And Valuation
Stuart Saunders 10/1/2018 2:44:49 AM

Inventors, do not trust johnson and Johnson $JNJ

Johnson & Johnson Upgraded To Neutral From Sell At Goldman Sachs
Bill Myers 7/12/2018 12:37:26 PM

Still not impressed with $JNJ.

1 to 4 of 4 comments